RecruitingNCT06580860

Psychiatric Multi-omics and Neuroimaging Project

Psychiatric Multi-omics and Neuroimaging Project Database

Sponsor

mingjun Zhong

Enrollment

1,899 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Healthy Control Mental Disorders

Summary

This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.

Eligibility

Min Age: 13 YearsMax Age: 35 Years

Inclusion Criteria4

Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age)
Course of disease: \<24 months
Priority is given to patients who have never taken medicine or duration of drug use \< 2 weeks
No nuclear magnetic contraindications.

Exclusion Criteria3

Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence
Have a major physical disease or infectious disease
History of coma and serious neurological disease 4.MRI contraindications.

Interventions

DRUGAntipsychotic drugs, antidepressants, mood stabilizers, and sleep aids

Patients with mental disorders should take the appropriate medicine as prescribed by the doctor，and the health norms are not required to take medicine.This study will not interfere with the medication regimen of doctors.